AI-powered precision neuropsychiatry
Our predictive biomarker platform delivers personalized assessments of brain health to accelerate therapeutics for patients with psychiatric & neurological disorders.
We fuse generative AI with computational neuroscience
Our platform's algorithms are rigorously trained to model the brain's inherent complexity. We can differentiate major psychiatric disorders (MDD, ADHD, PTSD, OCD, SCZ) to predict treatment response up to 50% better than current “state of the art.”
Our solutions
Accelerate clinical trials and therapy development
Using cross-validated AI/ML models, our biomarker platform de-risks both clinical and preclinical R&D to bring innovative therapies to patients sooner. We generate prospective insights on dosing, efficacy, adverse events, placebo, indication selection, digital twins & much more.
Help providers deliver effective treatments
Our clinic integrations eliminate the trial-and-error approach to mental health and neurological care. Through the analysis of LLMs, psychometrics, EEG/ECG, and VR assessment, we help care providers better understand patient conditions, measure progress & improve outcomes.
Empower everyone to own & track their brain health
There’s nothing more critical to overall performance than optimizing the brain’s function. Our technology generates reports and insights for biohackers, early adopters of psychedelic medicine, longevity & anti-aging, or anyone that values objective measurements into their health.
Our partners
Award-winning predictive capabilities
In an international competition to validate clinically-actionable biomarkers, our approach ranks #1 among dozens of data science teams.
Meet the executive & computational team
We bring together the sharpest minds in computational neuroscience, generative artificial intelligence, integrative neurotechnology, psychedelic medicine & clinical care innovation, including experimental psychiatrists and open science pioneers with 100's of high impact papers & patents.
Consulting & operations
An extraordinarily interdisciplinary group of academic, nonprofit, and industry experts across pharmaceutical, medical device, neuroimaging, multiomics, natural language processing, legal & regulatory domains.
Our advisory board
We’re fortunate to benefit from the collective wisdom of the most (in our opinion) innovative and reputable figures in precision neuropsychiatry.
